Login / Signup
Gennie L Parkman
(Gennie Parkman)
ORCID
Publication Activity (10 Years)
Years Active: 2020-2023
Publications (10 Years): 3
Top Topics
Tyrosine Kinase
Anti Inflammatory
Basal Cell Carcinoma
Top Venues
Experimental dermatology
Molecular cancer therapeutics
Pigment cell & melanoma research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Gennie L Parkman
,
Tursun Turapov
,
David A Kircher
,
William J Burnett
,
Christopher M Stehn
,
Kayla O'Toole
,
Katie M Culver
,
Ashley T Chadwick
,
Riley C Elmer
,
Ryan Flaherty
,
Karly A Stanley
,
Mona Foth
,
David H Lum
,
Robert L Judson
,
John E Friend
,
Matthew W VanBrocklin
,
Martin McMahon
,
Sheri L Holmen
Genetic silencing of AKT induces melanoma cell death via mTOR suppression.
Molecular cancer therapeutics
(2023)
Gennie L Parkman
,
Mona Foth
,
David A Kircher
,
Sheri L Holmen
,
Martin McMahon
The role of PI3'-lipid signalling in melanoma initiation, progression and maintenance.
Experimental dermatology
(2021)
Mona Foth
,
Gennie L Parkman
,
Benjamin Battistone
,
Martin McMahon
RAC1mutation is not a predictive biomarker for PI3'-kinase-β-selective pathway-targeted therapy.
Pigment cell & melanoma research
33 (5) (2020)